Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
130
self-reported 51–200 band
Founded
Not recorded
Legal entities
1
ABR
Office countries
1
1 address
Funding rounds
11
Series D · Sep 2025 · US$ 31.9M
Company type
Privately Held
self-reported
Legal entity
1 brand → 1 confirmed entity
Vaxxas Pty Ltd
ABN16152205242
Legal entities
Show as table · Vaxxas: 1 registry entity
| Vaxxas Pty Ltd | ABN 16152205242 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
Vaxxas is commercializing novel technology that dramatically enhances the performance of existing and next-generation vaccines. The company believes its innovative needle-free technology will help the world in rethinking what's possible with vaccines.
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AUBrisbanePrimary
Grid intelligence Members
Funding
Rounds11
Round typeSeries D · venture round
Amount (USD)31,900,000
Stage rank5
Investors named1
Since last round3 mo
Funding
Show as table · 11 funding rounds
| Rounds | 11 |
|---|---|
| Axis | 2025 to 2027 |
| Series D · 25 Sep 2025 | US$ 31.9M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
FAQ
Which legal entity operates under Vaxxas?
One Queensland entity on the ABR: Vaxxas Pty Ltd (ABN 16 152 205 242), high confidence.
How many people work at Vaxxas?
130 counted staff profiles at January 2026, inside the self-reported 51–200 band.
Where does Vaxxas have offices?
One address on record, Australia only. Primary: Brisbane.
Has Vaxxas raised funding?
11 rounds. Latest 25 September 2025: Series D, US$31,900,000, investor SPRIM Global Investments.
Which companies are listed alongside Vaxxas?
59 profiles list Vaxxas as a peer — 99th percentile in Biotechnology Research. It lists ten peers of its own. Translational Research Institute Australia and Microba list it back.